| Literature DB >> 35975026 |
Chunyue Weng1,2, Zheyan Mi1,2, Meijing Li1,2, Haibin Qin1,2, Zhongce Hu1,2, Zhiqiang Liu1,2, Yuguo Zheng1,2, Yuanshan Wang1,2.
Abstract
To improve S-Adenosyl-L-methionine (a compound with important physiological functions, SAM) production, atmospheric and room temperature plasma and ultraviolet-LiCl mutagenesis were carried out with Saccharomyces cerevisiae strain ZY 1-5. The mutants were screened with ethionine, L-methionine, nystatin and cordycepin as screening agents. Adaptive evolution of a positive mutant UV6-69 was further performed by droplet microfluidics cultivation with ethionine as screening pressure. After adaptation, mutant T11-1 was obtained. Its SAM titer in shake flask fermentation reached 1.31 g/L, which was 191% higher than that of strain ZY 1-5. Under optimal conditions, the SAM titer and biomass of mutant T11-1 in 5 L bioreactor reached 10.72 g/L and 105.9 g dcw/L (142.86% and 34.22% higher than those of strain ZY 1-5), respectively. Comparative transcriptome analysis between strain ZY 1-5 and mutant T11-1 revealed the enhancements in TCA cycle and gluconeogenesis/glycolysis pathways as well as the inhibitions in serine and ergosterol synthesis of mutant T11-1. The elevated SAM synthesis of mutant T11-1 may attribute to the above changes. Taken together, this study is helpful for industrial production of SAM. © King Abdulaziz City for Science and Technology 2022, Springer Nature or its licensor holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.Entities:
Keywords: Atmospheric and room temperature plasma; Droplet microfluidic; S-Adenosyl-L-methionine; Saccharomyces cerevisiae
Year: 2022 PMID: 35975026 PMCID: PMC9375785 DOI: 10.1007/s13205-022-03297-x
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.893